n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Jinno, Y; Kaneta, S; Miwa, A; Ogawa, N; Takeuchi, A; Yokoyama, T | 1 |
| Fukata, Y; Fukushima, H; Harada, K; Kaneta, S; Miwa, A; Ogawa, N | 1 |
| Grover, GJ | 1 |
1 review(s) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Disease Models, Animal
| Article | Year |
|---|---|
The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the future.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzopyrans; Cardiotonic Agents; Disease Models, Animal; Guanidines; Humans; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyridines | 1996 |
2 other study(ies) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Disease Models, Animal
| Article | Year |
|---|---|
Effect of KRN2391 on canine ventricular arrhythmia models.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Digitalis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Epinephrine; Female; Male; Plants, Medicinal; Plants, Toxic; Pyridines; Vasodilator Agents; Ventricular Function | 1994 |
Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
Topics: Angina Pectoris; Animals; Disease Models, Animal; Electrocardiography; Injections, Intravenous; Isoproterenol; Male; Methacholine Chloride; Niacinamide; Nicorandil; Nifedipine; Pyridines; Rats; Rats, Wistar; Vasodilator Agents | 1993 |